WELL Health Technologies Toekomstige groei

Future criteriumcontroles 4/6

De verwachting is dat WELL Health Technologies de winst en omzet met respectievelijk 25.6% en 17.7% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 30.2% per jaar.

Belangrijke informatie

25.6%

Groei van de winst

30.2%

Groei van de winst per aandeel

Healthcare winstgroei	59.4%
Inkomstengroei	17.7%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Good
Laatst bijgewerkt	28 Apr 2025

Recente toekomstige groei-updates

Recent updates

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Apr 23

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Apr 22

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Apr 01

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

Mar 29

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

Jan 19 Market consolidation and clinic efficiency initiatives could significantly enhance WELL Health's revenue growth and net margins.

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Dec 31

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

Nov 29

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Nov 11

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11

Winst- en omzetgroeiprognoses

TSX:WELL - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CAD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2027	1,722	81	N/A	197	5
12/31/2026	1,531	54	89	154	13
12/31/2025	1,370	25	82	118	14
12/31/2024	920	33	-17	10	N/A
9/30/2024	958	73	112	127	N/A
6/30/2024	910	147	67	89	N/A
3/31/2024	838	30	49	68	N/A
12/31/2023	776	0	41	66	N/A
9/30/2023	701	-7	60	81	N/A
6/30/2023	643	-4	61	76	N/A
3/31/2023	612	-5	67	81	N/A
12/31/2022	569	1	70	77	N/A
9/30/2022	528	-29	20	56	N/A
6/30/2022	482	-37	5	49	N/A
3/31/2022	403	-45	-19	34	N/A
12/31/2021	302	-44	-30	22	N/A
9/30/2021	204	-29	-13	10	N/A
6/30/2021	117	-21	-10	2	N/A
3/31/2021	66	-9	-4	-4	N/A
12/31/2020	50	-4	-7	-5	N/A
9/30/2020	43	-9	-5	-4	N/A
6/30/2020	39	-10	-4	-3	N/A
3/31/2020	36	-8	-4	-3	N/A
12/31/2019	33	-8	-3	-3	N/A
12/31/2018	9	-2	-1	-1	N/A
10/31/2018	6	-2	N/A	-1	N/A
7/31/2018	4	-6	N/A	-1	N/A
4/30/2018	2	-6	N/A	-1	N/A
1/31/2018	0	-6	N/A	-1	N/A
10/31/2017	N/A	-1	N/A	-1	N/A
7/31/2017	0	-1	N/A	-1	N/A
3/31/2017	0	0	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
10/31/2016	0	-1	N/A	0	N/A
12/31/2015	0	-1	N/A	0	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei WELL ( 25.6% per jaar) ligt boven de spaarquote ( 2.4% ).

Winst versus markt: De winst van WELL ( 25.6% per jaar) zal naar verwachting sneller groeien dan de Canadian markt ( 16.5% per jaar).

Hoge groeiwinsten: De winst van WELL zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van WELL ( 17.7% per jaar) zal naar verwachting sneller groeien dan de markt Canadian ( 4.9% per jaar).

Hoge groei-inkomsten: De omzet van WELL ( 17.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van WELL naar verwachting over 3 jaar hoog zal zijn

Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2025/05/01 23:16
Aandelenkoers aan het einde van de dag	2025/05/01 00:00
Inkomsten	2024/12/31
Jaarlijkse inkomsten	2024/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

WELL Health Technologies Corp. wordt gevolgd door 15 analisten. 14 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Gabriel Leung	Beacon Securities Limited
Douglas Taylor	Canaccord Genuity
Scott Fletcher	CIBC Capital Markets

WELL Health Technologies Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus revenue estimates increase by 15%

WELL Health Technologies Corp. Provides Earnings Guidance for 2025

Price target increased by 8.9% to CA$8.37

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

Recent updates

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Consensus revenue estimates increase by 15%

Full year 2024 earnings: EPS and revenues miss analyst expectations

WELL Health Technologies Corp. Provides Earnings Guidance for 2025

WELL Health Technologies Corp., Annual General Meeting, Jun 19, 2025

WELL Health Technologies Corp. to Report Q4, 2024 Results on Apr 14, 2025

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Investor sentiment deteriorates as stock falls 21%

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Microquest Inc

Independent Director exercised options and sold CA$198k worth of stock

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Price target increased by 8.9% to CA$8.37

Investor sentiment improves as stock rises 23%

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Chief Operating Officer exercised options to buy CA$1.6m worth of stock.

New major risk - Revenue and earnings growth

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Independent Director exercised options and sold CA$144k worth of stock

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Independent Director recently sold CA$160k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.

Consensus estimates of losses per share improve by 22%

Second quarter 2023 earnings: EPS exceeds analyst expectations

WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023

Founder exercised options and sold CA$527k worth of stock

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc.

Consensus EPS estimates fall by 11%, revenue upgraded

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Consensus EPS estimates fall by 11%, revenue upgraded

Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023

Chief Financial Officer exercised options to buy CA$1.5m worth of stock.

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

Founder exercised options and sold CA$204k worth of stock